Literature DB >> 16099720

Chemokines, chemokine receptors and pain.

Catherine Abbadie1.   

Abstract

Many patients suffer from neuropathic pain as a result of injury to the peripheral nervous system (e.g. post-herpetic neuralgia or diabetic neuropathy) or to the central nervous system (e.g. spinal cord injury or stroke). The most distinctive symptom of neuropathic pain is allodynia, whereby normally non-painful stimuli, such as light touch, become painful. Traditionally, inflammatory and neuropathic pain syndromes have been considered distinct entities; however, recent evidence belies this strict dichotomy. Nerve damage can stimulate macrophage infiltration and increase the number of activated T cells. Under these conditions, neuroinflammatory and immune responses contribute as much to the development and maintenance of pain as the initial damage itself. Recently, studies using animal models have shown that upregulation of chemokines is one of the mechanisms underlying the development and maintenance of chronic pain.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16099720     DOI: 10.1016/j.it.2005.08.001

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  50 in total

1.  Painful pathways induced by TLR stimulation of dorsal root ganglion neurons.

Authors:  Jia Qi; Krisztina Buzas; Huiting Fan; Jeffrey I Cohen; Kening Wang; Erik Mont; Dennis Klinman; Joost J Oppenheim; O M Zack Howard
Journal:  J Immunol       Date:  2011-04-22       Impact factor: 5.422

Review 2.  Chemokines, neuronal-glial interactions, and central processing of neuropathic pain.

Authors:  Yong-Jing Gao; Ru-Rong Ji
Journal:  Pharmacol Ther       Date:  2010-02-01       Impact factor: 12.310

3.  Norman Cousins Lecture. Glia as the "bad guys": implications for improving clinical pain control and the clinical utility of opioids.

Authors:  Linda R Watkins; Mark R Hutchinson; Annemarie Ledeboer; Julie Wieseler-Frank; Erin D Milligan; Steven F Maier
Journal:  Brain Behav Immun       Date:  2006-12-18       Impact factor: 7.217

Review 4.  In search of analgesia: emerging roles of GPCRs in pain.

Authors:  Laura S Stone; Derek C Molliver
Journal:  Mol Interv       Date:  2009-10

5.  ISSLS PRIZE IN CLINICAL SCIENCE 2021: What are the risk factors for low back pain flares and does this depend on how flare is defined?

Authors:  Nathalia Costa; Esther Smits; Jessica Kasza; Sauro Salomoni; Manuela Ferreira; Michael Sullivan; Paul W Hodges
Journal:  Eur Spine J       Date:  2021-02-03       Impact factor: 3.134

Review 6.  Chemokines and pain mechanisms.

Authors:  Catherine Abbadie; Sonia Bhangoo; Yves De Koninck; Marzia Malcangio; Stéphane Melik-Parsadaniantz; Fletcher A White
Journal:  Brain Res Rev       Date:  2008-12-25

7.  Urinary bladder function and somatic sensitivity in vasoactive intestinal polypeptide (VIP)-/- mice.

Authors:  Simon Studeny; Bopaiah P Cheppudira; Susan Meyers; Elena M Balestreire; Gerard Apodaca; Lori A Birder; Karen M Braas; James A Waschek; Victor May; Margaret A Vizzard
Journal:  J Mol Neurosci       Date:  2008-06-17       Impact factor: 3.444

8.  Psychologic and biologic factors associated with fatigue in patients with persistent radiculopathy.

Authors:  Angela Starkweather
Journal:  Pain Manag Nurs       Date:  2010-12-30       Impact factor: 1.929

Review 9.  Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology.

Authors:  Richard M Ransohoff
Journal:  Immunity       Date:  2009-11-20       Impact factor: 31.745

10.  Crosstalk between spinal astrocytes and neurons in nerve injury-induced neuropathic pain.

Authors:  Wei Wang; Wen Wang; Xiaopeng Mei; Jing Huang; Yanyan Wei; Yayun Wang; Shengxi Wu; Yunqing Li
Journal:  PLoS One       Date:  2009-09-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.